Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).
3d agoen
From the article
Conditions : Chronic Spontaneous Urticaria (CSU); Healthy Volunteers Interventions : Drug: Alpha-0261; Other: Placebo Sponsors : AlphaMol Science Ltd. (Shanghai) Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus
This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce
https://doi.org/10.1001/jamaneurol.2026.0989
doi.org·1mo ago
EAN 2026: Positive trial data for cemdisiran underscores potential for use in generalized MG, says GlobalData
globaldata.com·8d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.